Patient-reported outcomes in a prospective real-world study of droxidopa for the treatment of neurogenic orthostatic hypotension

被引：0
|
作者：
Kymes, S.
Francois, C.
McLeod, K.
Duhig, A.
Ogbonnaya, A.
Quillen, A.
Cannon, J.
Shibao, C.
Yue, B.
Biaggioni, I.
机构：
来源：
MOVEMENT DISORDERS | 2017年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
281
引用
收藏
页数：1
相关论文
共 50 条
  • [21] A Mixed Treatment Comparison of Droxidopa and Midodrine for the Treatment of Neurogenic Orthostatic Hypotension
    Chen, J. J.
    Han, Y.
    Tang, J.
    Dashtipour, K.
    [J]. MOVEMENT DISORDERS, 2017, 32 (09) : E5 - E6
  • [22] Defining successful treatment of neurogenic orthostatic hypotension with droxidopa in a patient with multiple system atrophy
    Brent P. Goodman
    Fiona Gupta
    [J]. Clinical Autonomic Research, 2017, 27 : 21 - 23
  • [23] A MIXED TREATMENT COMPARISON OF DROXIDOPA AND MIDODRINE FOR THE TREATMENT OF NEUROGENIC ORTHOSTATIC HYPOTENSION
    Joe, Y.
    Joe, W.
    Chen, J. J.
    [J]. VALUE IN HEALTH, 2017, 20 (05) : A189 - A189
  • [24] Use of droxidopa for the long-term treatment of neurogenic orthostatic hypotension
    Raj, Satish R.
    Hewitt, Lawrence Arthur
    [J]. EUROPEAN HEART JOURNAL, 2019, 40 (01) : 69 - 70
  • [25] Characteristics of patients initiating droxidopa for the treatment of neurogenic orthostatic hypotension (nOH)
    Francois, C.
    McLeod, K.
    Duhig, A.
    Ogbonnaya, A.
    Quillen, A.
    Cannon, J.
    Padilla, B.
    Shibao, C. A.
    Biaggioni, I.
    [J]. MOVEMENT DISORDERS, 2016, 31 : S147 - S147
  • [26] Analysis of Droxidopa for the Treatment of Neurogenic Orthostatic Hypotension in Patients with Parkinson Disease
    Hewitt, L. Arthur
    Ziemann, Adam
    Biaggioni, Italo
    Cherny, Katya
    Vernino, Steven
    [J]. NEUROLOGY, 2017, 88
  • [27] Droxidopa for the treatment of neurogenic orthostatic hypotension and other symptoms of neurodegenerative disorders
    Perez-Lloret, Santiago
    Rey, Maria Veronica
    Pavy-Le Traon, Anne
    Rascol, Olivier
    [J]. EXPERT OPINION ON ORPHAN DRUGS, 2014, 2 (05): : 509 - 522
  • [28] Analysis of Droxidopa for the Treatment of Neurogenic Orthostatic Hypotension in Patients with Parkinson Disease
    Hewitt, L. A.
    Biaggioni, I.
    Ziemann, A.
    Vernino, S.
    [J]. MOVEMENT DISORDERS, 2017, 32 (09) : E8 - E8
  • [29] Adding droxidopa to fludrocortisone or midodrine in a patient with neurogenic orthostatic hypotension and Parkinson disease
    Kremens, Daniel
    Lew, Mark
    Claassen, Daniel
    Goodman, Brent P.
    [J]. CLINICAL AUTONOMIC RESEARCH, 2017, 27 : S29 - S31
  • [30] Adding droxidopa to fludrocortisone or midodrine in a patient with neurogenic orthostatic hypotension and Parkinson disease
    Daniel Kremens
    Mark Lew
    Daniel Claassen
    Brent P. Goodman
    [J]. Clinical Autonomic Research, 2017, 27 : 29 - 31
12345